Record Display for the EPA National Library Catalog
RECORD NUMBER: 4 OF 9Main Title | Evaluation of the potential carcinogenicity of aziridine (151-56-4) / | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CORP Author | Syracuse Research Corp., NY. ;Environmental Monitoring and Services, Inc., Washington, DC.;Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment. | |||||||||||
Publisher | U.S. Environmental Protection Agency, Office of Emergency and Remedial Response ; | |||||||||||
Year Published | 1988 | |||||||||||
Report Number | EPA/600/8-91/068; EPA-68-03-3112; EPA-68-03-3182 | |||||||||||
Stock Number | PB93-184919 | |||||||||||
Subjects | Aromatic compounds--Carcinogenicity ; Aziridine--Carcinogenicity | |||||||||||
Additional Subjects | Aziridines ; Toxicity ; Risk assessment ; Public health ; Exposure ; Neoplasms ; Hazardous materials ; Tolerances(Physiology) ; Carcinogenicity ; Dose-response relationships ; CAS Registry No: 151-56-4 | |||||||||||
Holdings |
|
|||||||||||
Collation | 17 pages ; 28 cm | |||||||||||
Abstract | Aziridine is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is 'Sufficient', and the evidence from human studies is 'No Data'. The potency factor (F) for aziridine is estimated to be 336 (mg/kg/day)(-1), placing it in potency group 1 according to the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, aziridine is assigned a 'HIGH' hazard ranking for the purposes of RQ adjustment. |
|||||||||||
Notes | Cover title. "June 1988." Includes bibliographical references. Microfiche. |